Sleepiness Could Be Triggered by a Power Overload in Our Brain
Researchers from the University of Oxford in the UK have identified our cell's mitochondria as responsible for signaling when the body has to get some shut-eye as soon as possible.
These tiny power generators cause a kind of metabolic overload in sleep-regulating neurons, the researchers suggest, which in simple terms indicates when our brain is running on empty. Through sleep, this overload can be reset, ensuring the brain remains in a healthy state.
Related:
"We set out to understand what sleep is for, and why we feel the need to sleep at all," says physiologist Gero Miesenböck. "Despite decades of research, no one had identified a clear physical trigger."
"Our findings show that the answer may lie in the very process that fuels our bodies: aerobic metabolism."
The team studied neurons responsible for regulating sleep in fruit flies, which have enough biological similarities to humans to make them useful for research. Through a comparison of well-rested and sleep-deprived fruit flies, the researchers identified differences in gene activity and electrical signaling.
Overloaded mitochondria in sleep-deprived brains were found to shed electrons, increasing the generation of harmful waste products. The sleep-regulating neurons respond to these molecules by going into overdrive, making sleep a top biological priority.
"You don't want your mitochondria to leak too many electrons," says neuroscientist Raffaele Sarnataro. "When they do, they generate reactive molecules that damage cells."
Genetically engineering flies with a higher production of electrons in their sleep-regulating cells resulted in fruit flies that also slept more. Similarly, flies with a reduced level of electron generation slept less.
There are, of course, other pressures on sleep, from how many coffees you have per day to the alignment of your circadian rhythm – the internal schedule that tells your body when it's time for bed. But now we have an actual cellular mechanism controlling sleep, and showing why we can't do without it.
Anything new we learn about sleep can inform the treatment of sleep disorders and even neurological conditions such as Alzheimer's. These diseases are closely linked to sleep and the way it protects the brain, and connections to mitochondria could be something for future studies to investigate.
The study also joins some of the dots between metabolism, sleep, and lifespan. Smaller animals tend to sleep more and live shorter lives, and the activity of mitochondria – and the waste that needs clearing up – could be part of the reason why.
"This research answers one of biology's big mysteries," says Sarnataro. "Why do we need sleep? The answer appears to be written into the very way our cells convert oxygen into energy."
The research has been published in Nature.
Related News
Study Reveals Key Way to Slow Chronic Illness in Old Age
Liver Cancer Predicted to Double by 2050, But There Is Hope
One Weekend Habit May Cut Risk of Heart-Related Death by 33%, Study Finds
Solve the daily Crossword
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
20 hours ago
- Fox News
Alzheimer's researchers say targeting brain sugar could help protect against dementia
The brain has a hidden "sugar code" that could lead to better treatments for neurological diseases like Alzheimer's, according to new research. A study recently published in the journal Nature Metabolism found that breaking down glycogen (stored glucose) in the brain could reduce the buildup of toxic proteins linked to the common dementia. This was one of the first studies to show that glycogen may actively influence brain health and disease, according to lead author Dr. Pankaj Kapahi, a professor at the Buck Institute for Research on Aging in California. "The study began with fruit flies (Drosophila) that were genetically modified to mimic tauopathy, a condition where a protein called tau builds up in the brain, similar to what happens in Alzheimer's disease," Kapahi told Fox News Digital. The flies used in the study were found to have brain damage and shortened lifespans, according to the researcher. To ensure that the results could translate to humans, the research team also studied nerve cells made in the lab from human patient cells carrying tau mutations, as well as postmortem brain samples from people who had Alzheimer's or related conditions, according to a press release. In both the fly and human models, the researchers found increased levels of glycogen (stored glucose) in the brain, as well as signs that glycogen breakdown was impaired, Kapahi told Fox News Digital. This was a surprising discovery, as researchers previously thought glycogen was mainly stored in the muscles and liver. They also found that the excess glycogen contributed to disease. The tau proteins in the scientists' models interacted with glycogen, blocking it from breaking down, and the nerves lost their ability to ward off cell damage. However, the researchers found they could decrease damage to the fruit flies and human nerves by boosting an enzyme called glycogen phosphorylase (GlyP), which breaks down glycogen. "The next step in the process may be mopping up potentially damaging free radicals roaming our brains." The nerve cells used the glycogen to fight against cell damage, suggesting that the enzymes responsible for breaking down sugar could be promising targets for future therapies. The researchers were also curious whether a restricted diet could improve the flies' brain health. When they reduced the amount of protein in the insects' diet, the flies indeed lived longer and their brain health improved. "We then discovered this improvement was linked to an increase in the breakdown of glycogen," Kapahi said. This led to the study's main finding — that breaking down glycogen in neurons can protect the brain from damage caused by tau buildup. The scientists also developed a drug using a special molecule called 8-Br-cAMP that replicated similar effects of dietary restriction, the press release noted. The authors clarified that they are not recommending low-protein diets just yet — but said this research could pave the way for dietary or drug-based strategies to help slow Alzheimer's and related diseases. Dr. Michael Okun, a Florida neurologist and medical advisor to the Parkinson's Foundation, was not involved in the study but commented on the significance of the findings. "Instead of funneling sugar into energy-burning processes, the broken-down glycogen seemed to be routed into an antioxidant-producing pathway," Okun, who is also author of "The Parkinson's Plan," told Fox News Digital. "The next step in the process may be mopping up potentially damaging free radicals roaming our brains," he said. Okun also confirmed that dietary restrictions activated a protective brain pathway and boosted the breakdown of brain sugar. "It ultimately reduced damage from the Alzheimer's-related tau protein," he said. The study — which was supported by the National Institutes of Health, as well as the American Federation of Aging Research and other sources — did have some limitations, the experts acknowledged. The researchers did not clarify whether breaking down brain glycogen could stop human brain cells from dying, Okun noted. "We still don't know if targeting glycogen breakdown will work in human patients — and most importantly, whether it will be a safe approach." "We don't yet know why glycogen builds up in disease, or whether it's a cause or a result of tau pathology — though our data suggest it may amplify disease progression," Kapahi added. The research was also conducted only on fly and human cell models and has not yet been tested on living humans. "We still don't know if targeting glycogen breakdown will work in human patients — and most importantly, whether it will be a safe approach," Okun said. Alzheimer's disease, the most common form of dementia in the U.S., affects more than seven million people in the U.S., according to the Alzheimer's Association. For more Health articles, visit The neurological disorder affects memory, thinking and behavior. There is no cure for the disease, but some medications can temporarily slow progression and improve quality of life.
Politico
3 days ago
- Politico
Senate appropriators defend the NIH
WASHINGTON WATCH Senate appropriators came out hard in support of the National Institutes of Health on Thursday, giving the agency a $400 million funding boost for the 2026 fiscal year. How so: The Senate Appropriations Committee upped the agency's budget to $48.7 billion in the 2026 funding bill that cleared the panel with a 26-3 vote Thursday. If the bill becomes law, it would increase cancer research by $150 million; Alzheimer's research by $100 million and amyotrophic lateral sclerosis, or ALS, research by $25 million. The NIH's National Institute of Allergy and Infectious Diseases and the Office of Research on Women's Health would each get a $30 million boost. Research on maternal mortality, diabetes and rare diseases would also see an increase, among others. Why it matters: The funding boost is a rebuke from both Republicans and Democrats to the Trump administration's demand to decrease the NIH funding in the next fiscal year by as much as 40 percent, or $18 billion. Senate Appropriations Chair Susan Collins (R-Maine) said the legislation 'prioritizes funding to help make Americans healthier and supports life-saving medical research.' Sen. Patty Murray (D-Wash.), the top Democrat on the panel, said the budget increase was a message to 'the scientists wondering if there will even be an NIH by the end of this administration. This committee's resounding message is: 'Yes, Congress has your back.'' Murray urged scientists to continue their research in the U.S. despite the efforts of other countries to lure them away. The appropriators also adopted an amendment Thursday that would limit the Trump administration's control over NIH research funding. An amendment in the bill's manager's package limits the administration's plan to shift funding for most NIH grants from a multiyear schedule to an upfront single-year payment. The amendment states that no funds appropriated in the fiscal 2026 spending bill can be used to increase the proportion of grants fully funded in the first year of the award, compared with fiscal 2024. The NIH can only increase that proportion of forward-funded grants if the agency ensures it isn't cutting grants to do so. What's next: The bill is cleared for floor action. But congressional leaders haven't started bipartisan negotiations toward overall government funding totals, increasing the odds that lawmakers will again resort to a stopgap funding patch before the next fiscal year starts on Oct. 1. WELCOME TO FUTURE PULSE This is where we explore the ideas and innovators shaping health care. Peacock feathers have reflective structures that can amplify light into a laser beam, Science reports. Share any thoughts, news, tips and feedback with Carmen Paun at cpaun@ Ruth Reader at rreader@ or Erin Schumaker at eschumaker@ Want to share a tip securely? Message us on Signal: CarmenP.82, RuthReader.02 or ErinSchumaker.01. MORNING MONEY: CAPITAL RISK — POLITICO's flagship financial newsletter has a new Friday edition built for the economic era we're living in: one shaped by political volatility, disruption and a wave of policy decisions with sector-wide consequences. Each week, Morning Money: Capital Risk brings sharp reporting and analysis on how political risk is moving markets and how investors are adapting. Want to know how health care regulation, tariffs, or court rulings could ripple through the economy? Start here. WORLD VIEW A draft United Nations plan to make the world healthier no longer includes several targets cracking down on sugary drinks, trans fats and tobacco to prevent and control noncommunicable diseases globally. Struck down: A target of 80 percent of countries taxing sugary drinks at levels recommended by the World Health Organization by 2030, POLITICO's Rory O'Neill reports. That goal was a pillar of the initial draft, which will take the form of a nonbinding political declaration world leaders are expected to endorse at a Sept. 25 meeting in New York, on the margins of the U.N. General Assembly. The latest version has also dropped commitments to eliminate trans fats and aims instead to reduce them to the 'lowest level possible.' It also requires front-of-pack labels with nutritional information. A requirement for health warnings on tobacco packaging to be graphic and accompanied by elements that make it unattractive to consumers is also gone. The new draft has softer language on tobacco advertising, requiring countries to restrict it instead of eliminate it. 'Make no mistake, the Declaration in its current form is a backslide,' said Alison Cox, director of policy and advocacy at the NCD Alliance, in a statement. The alliance is a Switzerland-based civil society group working to promote chronic disease prevention. Why it matters: World leaders aim to reduce premature mortality from noncommunicable diseases such as heart disease, cancer and diabetes by 2030 through prevention and treatment and to improve mental health and well-being globally. Noncommunicable diseases killed 18 million people under age 70 in 2021, according to the WHO. Most deaths were in low- and middle-income countries. The aims align with the U.S. Health Secretary Robert F. Kennedy Jr.'s Make America Healthy Again agenda, but it's unclear how much the U.S. is involved in drafting the final text. HHS did not respond to a request for comment. What's next: Negotiators are meeting this week in New York to discuss the text.
Yahoo
4 days ago
- Yahoo
Three factors will stall dementia and the aging process, according to new U.S. study
By 2050, over 1.7 million Canadians are projected to be living with dementia. This represents an increase of 187 per cent compared to 2020, when approximately 597,300 Canadians were living with dementia, according to the Alzheimer's Society of Canada. Dementia describes the decline of mental ability, while Alzheimer's Disease is the medical term for the brain disease that commonly causes dementia. Researchers are now saying certain lifestyle changes can stave off mental decline. A new U.S. study sets out what Alzheimer's researchers are calling the strongest evidence yet regarding what is involved in slowing the aging process and improving cognition. It comes down to three key factors: a diet heavy on leafy greens, berries and grains, regular moderate exercise and ongoing social interaction. Regular cardiovascular monitoring is also a factor. Jessica Langbaum, senior director of research strategy at the Banner Alzheimer's Institute in Phoenix was not involved directly in the research but she presented the findings at an annual conference of experts in Toronto on Wednesday. The Alzheimer's Association International Conference (AAIC) is the largest international meeting dedicated to advancing dementia science and clinical practice. This year's gathering brought together 8,000 scientists and clinicians from all over the world, with the goal of improving diagnosis, risk reduction and treatment. The study pulled together diet, exercise and socialization in one substantial, structured study of 2,100 people in their 60s and 70s at risk of developing dementia, showing that bad habits 'can really slow down memory and thinking' in adults at risk for cognitive impairment and dementia, Langbaum told the PBS New Hour in an interview on Wednesday evening. The subjects who participated in the study changed their habits, shifting from a sedentary lifestyle to an active one and improving their diet over a two-year period, resulting in cognitive function scores on par with people one or two years younger. That might not sound like much, but Langbaum says the results are significant evidence that change can occur without medication. 'And so, it's showing that we can change the trajectory of aging,' she said. There were two groups in the study. In one, lifestyle changes were structurally prescribed. In the other, the changes were self-directed. The results for the prescribed group were much better, but Langbaum says both groups showed improvement. The biggest challenge that study participants faced was sustaining a new exercise regime. Langbaum recommends people find something that they enjoy doing. 'If (you're) frustrated by it, (you're) just going to give up. But do something that you enjoy. Better yet, do it with somebody else or others around you because socialization is key, and lastly, something that you can adhere to, if you can schedule it. It's something that you can stay committed to.' Regarding nutrition she notes: 'We say what's good for the heart is good for the brain, so a nice balanced … nutritious diet with … those leafy greens, low in saturated fats, all of those things.' The American Alzheimer's Association spent close to US$50 million on the study. The National Institutes of Health spent even more to ensure many of the participants underwent brain scans, blood tests and sleep studies aimed at provide additional information down the road. Meanwhile, Langbaum expresses concern that structured intervention may not be sustainable in most communities. 'I think that's really the next stage of the research is, how do we make this scalable in communities so that people can implement these things into their daily lives?' The American Alzheimer's Association is planning to spend another US$40 million on implementing the lessons of the study. Langbaum says that will come with a change in the mindsets of doctors. They 'should be treating lifestyle interventions as they would a drug,' she told NPR. That would mean prescribing improved exercise and eating regimens and getting insurers to cover those prescriptions, she added. Our website is the place for the latest breaking news, exclusive scoops, longreads and provocative commentary. Please bookmark and sign up for our daily newsletter, Posted, here.
